RT Book, Section
A1 Hunt, William R.
A1 Tong, David
A1 Stecenko, Arlene
A2 McKean, Sylvia C.
A2 Ross, John J.
A2 Dressler, Daniel D.
A2 Scheurer, Danielle B.
SR Print(0)
ID 1137623287
T1 Cystic Fibrosis
T2 Principles and Practice of Hospital Medicine, 2e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9780071843133
LK accessmedicine.mhmedical.com/content.aspx?aid=1137623287
RD 2024/04/25
AB Key  Clinical  Questions  How  do  mutations  in  the  cystic  fibrosis  (CF)  gene  relate  to  the  clinical  manifestations  of  the  disease?  What  criteria  help  determine  when  a  CF  patient  should  be  admitted  to  the  hospital  for  respiratory  complications  of  the  disease?  What  treatment  modalities  are  most  effective  in  restoring  lung  function  to  baseline  for  CF  respiratory  exacerbations?  Why  is  CF-related  diabetes  (CFRD)  important  to  control  during  acute  pulmonary  exacerbations  as  well  as  at  baseline?  What  are  the  most  effective  treatment  modalities  for  the  two  most  common  pulmonary  complications  of  CF:  massive  hemoptysis  and  pneumothorax?